MEI Pharma (MEIP)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	23.74 mm	23.74 mm	23.74 mm	23.74 mm	23.74 mm	23.74 mm
Cash burn (monthly)	(no burn)	(no burn)	1.15 mm	3.38 mm	1.22 mm	3.00 mm
Cash used (since last report)	n/a	n/a	2.64 mm	7.77 mm	2.81 mm	6.90 mm
Cash remaining	n/a	n/a	21.10 mm	15.97 mm	20.93 mm	16.84 mm
Runway (months of cash)	n/a	n/a	18.3	4.7	17.1	5.6

Beta Read what these cash burn values mean

Financial data from MEI Pharma earnings reports.

Institutional ownership, Q4 2024

MEIP institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	37	35	+5.7%
Opened positions	8	6	+33.3%
Closed positions	6	8	-25.0%
Increased positions	4	6	-33.3%
Reduced positions	7	9	-22.2%

13F shares	Current	Prev Q	Change
Total value	6.43 bn	7.47 bn	-13.9%
Total shares	24.50 mm	24.54 mm	-0.1%
Total puts	12.60 k	0.00	NEW
Total calls	400.00	0.00	NEW
Total put/call ratio	31.5	–	–

Largest owners	Shares	Value	Change
Growth Equity Opportunities V	9.96 mm	$17.93 mm	0.0%
Biotechnology Value Fund L P	5.59 mm	$14.76 mm	0.0%
Vivo Opportunity	3.30 mm	$8.71 mm	0.0%
Helsinn Investment Fund	2.62 mm	$6.49 mm	0.0%
Anson Funds Management	1.09 mm	$2.69 bn	+0.0%
Cable Car Capital	611.44 k	$1.50 bn	0.0%
Vanguard	385.73 k	$948.89 mm	0.0%
Tang Capital Partners	326.08 k	$1.51 mm	0.0%
Renaissance Technologies	134.95 k	$331.97 mm	-2.0%
Acadian Asset Management	101.31 k	$249.00 k	-23.5%

Largest transactions	Shares	Bought/sold	Change
Citadel Advisors	36.67 k	+36.67 k	NEW
Acadian Asset Management	101.31 k	-31.05 k	-23.5%
NA.R National Bank of Canada	0.00	-26.51 k	EXIT
TD The Toronto-Dominion Bank	25.00 k	+25.00 k	NEW
Pensionmark Financial	0.00	-25.00 k	EXIT
Corsair Capital Management	0.00	-24.37 k	EXIT
NTRS Northern Trust	35.60 k	+12.56 k	+54.5%
Virtu Financial	10.74 k	+10.74 k	NEW
Squarepoint Ops	0.00	-10.73 k	EXIT
Susquehanna International	22.63 k	+9.25 k	+69.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MEIP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 May 24	Steven D Wood	Common Stock	Grant	Acquire A	No	No	3.1701	3,100	9.83 k	4,359
16 May 24	James P Flynn	Common Stock	Grant	Acquire A	No	No	3.1621	7,900	24.98 k	7,900
18 Dec 23	James P Flynn	Stock Option Common Stock	Grant	Acquire A	No	No	6.33	10,000	63.30 k	10,000
18 Dec 23	James P Flynn	Stock Options Common Stock	Grant	Acquire A	No	No	6.33	6,700	42.41 k	6,700
18 Dec 23	Steven D Wood	Stock Option Common Stock	Grant	Acquire A	No	No	6.19	10,000	61.90 k	10,000
18 Dec 23	Steven D Wood	Stock Option Common Stock	Grant	Acquire A	No	No	6.19	6,700	41.47 k	6,700

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

MEI Pharma Q2 EPS $(0.40) Up From $(1.66) YoY

12 Feb 25

MEI Pharma (NASDAQ:MEIP) reported quarterly losses of $(0.40) per share. This is a 75.9 percent increase over losses of $(1.66) per share from the same period last year.

Press releases

From Benzinga Pro

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

12 Feb 25

Evaluation of Strategic Alternatives is Ongoing MEI Pharma, Inc. (NASDAQ:MEIP) (the "Company") today reported results for its quarter ended December 31, 2024. As previously announced in July 2024, the Company is